Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2016/0168145 OXAZOLIDIN-2-ONE-PYRIMIDINE DERIVATIVES AND THE USE THEREOF AS PHOSPHATIDYLINOSITOL-3-KINASE INHIBITORS
The present invention relates to oxazolidin-2-one substituted pyrimidine compounds that act as PI3K (phosphatidylinositol-3-kinase) inhibitors, as well as...
2016/0168144 COMPOSITIONS AND METHODS FOR MODULATING THE ACTIVITY OF EPSTEIN-BARR NUCLEAR ANTIGEN 1
The present invention embraces compounds that modulate the activity of Epstein-Barr Nuclear Antigen 1 (EBNA1) protein and use thereof in methods for treating...
2016/0168143 SALTS OF DASATINIB IN CRYSTALLINE FORM
The present invention primarily relates to molecular crystalline substances, preferably salts of Dasatinib in crystalline form, comprising a compound of...
2016/0168142 SALTS OF DASATINIB IN AMORPHOUS FORM
The present invention primarily relates to salts of Dasatinib, wherein the salts are in amorphous form. The salts described herein preferably comprise a cation...
2016/0168141 ARYL SULTAM DERIVATIVES AS RORc MODULATORS
Compounds of the formula I: ##STR00001## or pharmaceutically acceptable salts thereof, wherein m, n, p, q, r, A, W, X.sup.1, X.sup.2, X.sup.3, X.sup.4, Y, Z,...
2016/0168140 HETEROCYCLIC COMPOUNDS AS ANTIBIOTIC POTENTIATORS
The invention relates to heterocyclic compounds and their use as antibiotics and/or as antibiotic potentiators. The compounds may act as colistin potentiators...
2016/0168139 NOVEL MORPHOLINE DERIVATIVE OR SALT THEREOF
There is provided a morpholine derivative represented by General Formula [1A] or a salt thereof. ##STR00001## (In the formula, a ring A represents a ring...
2016/0168138 PROCESS FOR THE PREPARATION OF SUVOREXANT AND INTERMEDIATES USEFUL IN THE SYNTHESIS OF SUVOREXANT
A novel processes for the preparation of suvorexant (formula I), its related compounds and its intermediates that are simple, economical and commercially...
2016/0168137 INHIBITORS OF HUMAN 12/15-LIPOXYGENASE
A systematic screening has revealed a family of compounds that exhibit inhibitory effects on 12/15-lipoxygenase. Accordingly, the present invention relates to...
2016/0168136 CRYSTAL HAVING SPECIFIC CRYSTAL HABIT AND PHARMACEUTICAL COMPOSITION CONTAINING THE CRYSTAL AS ACTIVE INGREDIENT
An object is to provide a crystal having a new crystal habit of luliconazole and expand the possibility of application to pharmaceuticals. Disclosed is a...
2016/0168135 OXINDOLE DERIVATIVES CARRYING AN OXETANE SUBSTITUENT ANDUSE THEREOF FOR TREATING VASOPRESSIN-RELATED DISEASES
The present invention relates to novel substituted oxindole derivatives, pharmaceutical compositions comprising them, and their use for the treatment of...
2016/0168134 NAMPT INHIBITORS
Disclosed are compounds which inhibit the activity of NAMPT, compositions containing the compounds and methods of treating diseases during which NAMPT is...
2016/0168133 Improved Process for the Preparation of Crystalline Form IV of Posaconazole
The present invention relates to an improved large scale process for the preparation of posaconazole form IV.
2016/0168132 DI(HETERO)ARYLAMIDES AND SULFONAMIDES, METHODS FOR THEIR PREPARATION AND THERAPEUTIC USES THEREOF
The present invention refers to compounds of formula (I): as well as to a method for their preparation, pharmaceutical compositions comprising the same, and...
2016/0168131 Substituted Quinazolin-4-one Derivatives
Provided are substituted quinazolin-4-one compounds of the formula (I) and/or pharmaceutically acceptable salts and/or solvates thereof, wherein R.sup.1,...
2016/0168130 HETEROARYL SUBSTITUTED PYRAZOLES
Compounds of formula (I), which are inhibitors of Bub 1 kinase, processes for their production and their use as pharmaceuticals. ##STR00001##
2016/0168129 QUINAZOLINE DERIVATIVES, COMPOSITIONS THEREOF, AND USE AS PHARMACEUTICALS
Disclosed herein are protein kinase inhibitors, more particularly novel quinazoline derivatives and pharmaceutical compositions thereof, and method of use...
2016/0168128 INHIBITORS OF CELLULAR NECROSIS AND RELATED METHODS
A compound having the following structure (I): ##STR00001## or a pharmaceutically acceptable salt, prodrug, stereoisomer or tautomer thereof, is provided....
2016/0168127 BENZOIMIDAZOLES AS PROLYL HYDROXYLASE INHIBITORS
The present invention is directed to benzoimidazole compounds of the formula: ##STR00001## and enantiomers, diastereomers, racemates, and pharmaceutically ...
2016/0168126 CHEMICAL COMPOUNDS
The invention relates to pyrrolone compounds of the formula (I) wherein X, R.sup.a, R.sup.b, R.sup.c, R.sup.1, R.sup.2 and R.sup.3 are as defined in the...
2016/0168125 WNT SIGNALING INHIBITOR
A Wnt signaling inhibitor which comprises, as an active ingredient, a fused-ring heterocyclic compound represented by the following formula (IA) or a...
2016/0168124 SUBSTITUTED PYRIDINE-PIPERAZINYL ANALOGUES AS RSV ANTIVIRAL COMPOUNDS
The invention concerns novel substituted pyridine-piperazinyl analogues of formula (I) having antiviral activity, in particular, having an inhibitory activity...
2016/0168123 INHIBITORS OF PLASMA KALLIKREIN
The present invention provides compounds of formula (I), compositions comprising such compounds; the use of such compounds in therapy (for example in the...
2016/0168122 NOVEL TRIAZINE DERIVATIVE
The purpose of the present invention is to provide a novel triazine derivative of the formula (I): ##STR00001## wherein R.sup.1 represents a substituted or...
2016/0168121 QUINOLINE DERIVATIVE
A compound represented by general formula (I) has a strong Axl inhibitory activity by introducing a distinctive bicyclic structure in which a saturated carbon...
2016/0168120 CRYSTALLINE FORMS OF A BIPHENYL COMPOUND
The invention provides crystalline forms of biphenyl-2-ylcarbamic acid 1-(2-{[4-(4-carbamoylpiperidin-1-ylmethyl)benzoyl]methylamino}ethyl)piper- idin-4-yl...
2016/0168119 AUTOTAXIN INHIBITORS
The present invention relates to novel compounds that are autotaxin inhibitors, processes for their preparation, pharmaceutical compositions and medicaments...
2016/0168118 N-(5-QUINOLIN-6-YL)PYRIDIN-3-YL) BENZSULFAMIDE DERIVATIVES, PREPARATION METHOD AND THERAPEUTIC USE THEREOF
The present invention relates to the field of medical technology, and in particular, to a variety of substituted N-(5-(quinolin-6-yl)pyridin-3-yl) ...
2016/0168117 ARYL ACETATE ONIUM MATERIALS
Acid generators comprising a carbocyclic aryl or heteroaromatic group substituted with at least one acetate moiety are provided. These acid generators are...
2016/0168116 IRE-1alpha Inhibitors
Compounds which directly inhibit IRE-1.alpha. activity in vitro, prodrugs, and pharmaceutically acceptable salts thereof. Such compounds and prodrugs are...
2016/0168115 SALT, ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN
A salt represented by formula (I): ##STR00001## wherein R.sup.1 and R.sup.2 independently represent a hydrogen atom, a hydroxy group or a C.sub.1 to C.sub.12...
2016/0168114 Oxone-Aceton Mediated Metal Free Preparation of Syn-Diols
The present invention disclose a simple and high yielding process of Oxone-acetone mediated metal free syn-dihydroxylation of benzo fused olefins of formula...
2016/0168113 INDENYL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND MEDICAL USES THEREOF
Disclosed are compounds, for example, compounds of formula I, ##STR00001## wherein R, R.sub.0, R.sub.1-R.sub.8, n, X, Y, Y', and E are as described herein,...
2016/0168112 METHOD FOR CONTINUOUSLY PRODUCING CYCLIC CARBONATE
Provided is a method for continuously producing a cyclic carbonate, by which generation of a glycol in a reaction for synthesizing a cyclic carbonate is...
2016/0168111 FORMATION OF CHIRAL 4-CHROMANONES USING CHIRAL PYRROLIDINES IN THE PRESENCE OF PHENOLS OR THIOPHENOLS
The present invention relates to a synthesis of chromanones or chromanes in a stereospecific matter in view of the 2-position in the chromanone or chromane...
2016/0168110 FORMATION OF CHIRAL 4-CHROMANONES USING CHIRAL PYRROLIDINES IN THE PRESENCE OF ACIDS
The present invention relates to a synthesis of chromanones or chromanes in a stereospecific matter in view of the 2-position in the chromanone or chromane...
2016/0168109 METHOD FOR PRODUCING N,N-DIALKYLHOMOFARNESIC ACID AMIDE
Provided are: a method for producing N,N-dialkylhomofarnesic acid amide, which is a precursor of (.+-.)-3a,6,6,9a-tetramethyldodecahydronaphtho[2.1-b]furan...
2016/0168108 METHOD OF TREATING OR PREVENTING RAS-MEDIATED DISEASES
Disclosed are compounds, for example, a compound of formula I, ##STR00001## wherein R, R.sub.0, R.sub.1-R.sub.8, n, X, Y, Y', and E are as described herein,...
2016/0168107 UTILIZING A MULTIPHASE REACTOR FOR THE CONVERSION OF BIOMASS TO PRODUCE SUBSTITUTED FURANS
The present disclosure provides methods to produce substituted furans (e.g., halomethylfurfural, hydroxymethylfurfural, and furfural), by acid-catalyzed...
2016/0168106 Manumycin-type metabolite called Colabomycin E which inhibits caspase 1 and creation of interleukins, strain...
A manumycin-type metabolite called Colabomycin E which inhibits caspase 1 and creation of interleukins, strain produces the Colabomycin E and a method of a...
2016/0168105 FORMULATIONS OF 2-(TERT-BUTYLAMINO)-4-((1R,3R,4R)-3-HYDROXY-4-METHYLCYCLOHEXYLAMINO)-PYRI- MIDINE-5-CARBOXAMIDE
Provided are pharmaceutical compositions and dosage forms of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyri- midine-5-carboxamide, or...
2016/0168104 PREPARATION OF AND FORMULATION COMPRISING A MEK INHIBITOR
The present invention relates to processes for preparing 6-(4-bromo-2-fluorophenylamino)-7-fluoro -3-methyl-3H-benzoimidazole-5-carboxylic acid...
2016/0168103 PREPARATION OF AND FORMULATION COMPRISING A MEK INHIBITOR
The present invention relates to processes for preparing 6-(4-bromo-2-fluorophenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-car- boxylic acid...
2016/0168102 PREPARATION OF AND FORMULATION COMPRISING A MEK INHIBITOR
The present invention relates to processes for preparing 6-(4-bromo-2-fluorophenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-car- boxylic acid...
2016/0168101 NOVEL COMPOUNDS
Compounds of formula (I) described herein are imidazolone derivatives having human neutrophil elastase (HNE) inhibitory properties and are useful for the...
2016/0168100 ANTI-HIV COMPOUNDS
This invention provides, among other things, tetrahydroisoquinolines useful for treating viral infections, pharmaceutical formulations containing such...
2016/0168099 NOVEL BISAMINOQUINOLINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS PREPARED THEREFROM AND THEIR USE
The present invention relates to novel bisaminoquinoline compounds, pharmaceutical compositions comprising these novel compounds and methods for inhibiting...
2016/0168098 COMPOSITIONS AND METHODS OF TREATING RETINAL DISEASE
Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or...
2016/0168097 PROCESS FOR THE PREPARATION OF AMIDES FROM HINDERED ANILINES CONTAINING A PERHALOALKYL GROUP
The present invention provides a novel and improved process for the production of the production of hindered anilines containing perfluoroalky groups in good...
2016/0168096 BIARYL DERIVATIVES AS GPR120 AGONISTS
The present invention relates to biaryl derivatives of Formula 1, a method for preparing the same, a pharmaceutical composition comprising the same and use...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.